| Microcompartmentation at the mitochondrial surface | Brdiczka, D.; Knoll, G.; Riesinger, I.; Weiler, U.; Klug, G.; Benz, R.; Krause, J. |
| The Prince Edward Island Bioscience cluster | Casper, S.; Krause, J.; MacNevin, A. |
| Characterization of Muscarinic Receptor in Guinea Pig Uterus Smooth Muscle | Doods, H. N.; Willim, K.; Krause, J. |
| Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybrids | Krause, J. |
| Hepatic uptake of tissue-type plasminogen activator is saturable | Krause, J.; Tanswell, P. |
| Properties of molecular variants of tissue-type plasminogen activator | Krause, J.; Tanswell, P. |
| Optimizing Productivity in a Matrix Structure | Krause, J. |
| Purification and characterization of the pore forming protein of yeast mitochondrial outer membrane | Ludwig, O.; Krause, J.; Hay, R.; Benz, R. |
| Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men | Müller, T. H.; Weisenberger, H.; Brickl, R.; Narjes, H.; Himmelsbach, F.; Krause, J. |
| Pharmaco-dynamics and-kinetics of BIBU 52, a platelet glycoprotein (GP) IIb/IIIa antagonist, and its orally active prodrug BIBU 104 in man | Müller, TH; Weisenberger, H.; Brickl, R.; Kirchner, M.; Narjes, H.; Himmelsbach, F.; Guth, B.; Krause, J. |
| Tolerability and platelet fibrinogen receptor occupancy (FRO) after oral treatment with BIBU 104 xx in healthy volunteers | Narjes, H.; Weisenberger, H.; Muller, TH; Deichsel, G.; Krause, J. |
| Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells. | Seydel, W.; Stang, E.; Roos, N.; Krause, J. |
| Tissue-type plasminogen activator and ovalbumin show colocalization after endocytosis in hepatic cells. | Stang, E.; Krause, J.; Berg, T.; Roos, N. |
| Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo. | Stang, E.; Krause, J.; Seydel, W.; Berg, T.; Roos, N. |
| Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells. | Stang, E.; Roos, N.; Schlüter, M.; Berg, T.; Krause, J. |
| Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver. | Tanswell, P.; Heinzel, G.; Greischel, A.; Krause, J. |
| Pharmacokinetics and isolated liver perfusion of carbohydrate modified recombinant tissue-type plasminogen activator | Tanswell, P.; Schlüter, M.; Krause, J. |
| Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator. | Tanswell, P.; Seifried, E.; Stang, E.; Krause, J. |
| Pharmacokinetics of Human Tissue-Type Plasminogen Activator | Tanswell, P.; Seifried, E.; Krause, J. |
| Hepatic Endocytosis of Tissue-Type Plasminogen Activator with Special Reference to the Sinusoidal Cells | Wisse, E.; Knook, D. L.; , |
| Balancing R&D and Commercialization Teams to Maximize Early Market Entry | Krause, J. |
| Aligning R&D and Commercial to Increase Productivity | Krause, J. |
| Strategic macro-environmental factor analysis for entry into the fish vaccines market in India | Pallapothu, Mahendra Kumar; Krause, Juergen |
| Gauging the market and non-market forces in Indian aquaculture industry for a strategic position in fish vaccines market | Pallapothu, Mahendra Kumar; Evans, Gary |
| Case study of interprovincial variations in patient access to Oncology drugs | Ballem, Katherine H. D.; Krause, Juergen |
| Porin pores of mitochondrial outer membranes from high and low eukaryotic cells | De Pinto, V.; Ludwig, O.; Krause, J.; Benz, R.; Palmieri, F. |
| Different neuropeptsde Y receptor subtypes in rat and rabbit vas deferens | Doods, H. N.; Krause, J. |
| Choosing job-related personality traits | Goffin, Richard D.; Rothstein, Mitchell G.; Rieder, Michael J.; Poole, Amanda; Krajewski, Henryk T.; Powell, Deborah M.; Blake Jelley, R.; Boyd, Allison; Mestdagh, Tracy |
| Incentives and alternative rating approaches | Jelley, R. B.; Goddin, R. D.; Powell, D. M.; Heneman, R. L. |
| Alterations in liver mitochondrial function as a result of fasting and exhaustive exercise. | Klug, G. A.; Krause, J.; Ostlund, AK; Knoll, G.; Brdiczka, D. |
| Localisation of fluorescence-labelled recombinant tissue-type Plasminogen activator (rt-PA) on thrombi in vitro | Krause, J.; Deutsch, H. |
| Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. | Krause, J.; Eva, C.; Seeburg, P. H.; Sprengel, R. |
| Localisation of fluorescence labelled recombinant tissue-type plasminogen activator (rt-PA) on thrombi in vitro | Krause, J.; Deutsch, H. |
| Cross-linking analysis of yeast mitochondrial outer membrane | Krause, J.; Hay, R.; Kowollik, C.; Brdiczka, D. |
| The degree of coupling of oxidative phosphorylation is varied physiologically | Krause, J.; Klug, G.; Brdiczka, D. |
| Inhibition of collagen-induced platelet aggregation by DT-TX 30, a combined thromboxane-synthetase inhibitor and -receptor antagonist in man ex vivo | Mueller, T.; Narjes, H.; Krause, J. |
| DT-TX 30, combining thromboxane-synthetase inhibition with -receptor antagonism, selectively prevents the formation of large thrombi in man ex vivo | Mueller, T.; Rahr, K., Narjes, H.; Krause, J. |
| Enrichment and biochemical characterization of boundary membrane contact sites from rat-liver mitochondria. | Ohlendieck, K.; Riesinger, I.; Adams, V.; Krause, J.; Brdiczka, D. |
| The binding of glycerol kinase to the outer membrane of rat liver mitochondria | Östlund, A. K.; Göhring, U.; Krause, J.; Brdiczka, D. |
| BIBP 3226, the first potent and selective non-peptide Y1 receptor antagonist | Rudolf, K.; Eberlein, W.; Engel, W.; Beck-Sickinger, AG; Dollinger, H.; Esser, F.; Schnorrengerg, G.; Mihm, G.; Wieland, H. A.; Entzeroth, M.; Wienen, W.; Krause, J.; Doods, H. N. |
| Characterization of the receptor mediating the hepatic catabolism of t-PA | Seydel, W.; Hoffmann, H.; Krause, J. |
| Endocytosis and intracellular processing of t-PA by rat liver cells | Seydel, W.; Hoffmann, H.; Krause, J. |
| Saturability of clearance of t-PA in three animal species and isolated perfused rat liver | Tanswell, P.; Heinzel, G.; Greischel, A.; Seydel, W.; Krause, J. |
| Nonlinear pharmacokinetics and isolated liver perfusion of carbohydrate-modified tissue-type plasminogen activator | Tanswell, P.; Schluter, M.; Krause, J. |
| The structure and function of the pore in the mitochondrial external membrane / Untersuchungen zur Struktur und Funktion der Pore in der Mitochondrialen Aubenmembran | Krause, J. |
| Die molekularbiologischen Eigenschaften des Gewebetyp-plasminogenactivators und seiner Varianten | Tanswell, P.; Krause, J. |
| Light induced fluorescence for predicting API content in tablets | Domike, Reuben; Ngai, Samuel; Cooney, Charles L. |
